Renal Cell Carcinoma (RCC) is a common type of genitourinary cancer. Despite progress in treatment, challenges such as drug resistance and disease recurrence remain, emphasizing the need for ongoing research to improve outcomes for RCC patients. Copper is essential for various biological processes, including iron intake, antioxidant/detoxification, and mitochondrial respiration. Cuproptosis, a type of cell death induced by copper and proteotoxicity, is closely linked to the TCA cycle and mitochondrial respiration and appears to play a significant role in cancer characteristics. There is also a strong connection between non-coding RNAs, cuproptosis, and cancer. The regulatory role of cuproptosis-related miRNAs in RCC prognosis is still not fully understood. In our current work, we have identified cuproptosis-related miRNAs and visualized them using CancerMIRNome. Potential miRNAs were determined through regression analysis, and gene enrichment analyses were conducted to understand their regulatory role in RCC development. Therefore, creating signatures of cuproptosis-related miRNAs may offer significant advantages and play a crucial role in the treatment and therapeutics of RCC.